Equities

Bonesupport Holding AB

Bonesupport Holding AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)353.80
  • Today's Change-5.00 / -1.39%
  • Shares traded85.72k
  • 1 Year change+122.94%
  • Beta0.9077
Data delayed at least 15 minutes, as of Nov 12 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments167201206
Total Receivables, Net1287145
Total Inventory835652
Prepaid expenses25115.71
Other current assets, total------
Total current assets403339308
Property, plant & equipment, net242527
Goodwill, net------
Intangibles, net128.388.37
Long term investments0.000.00--
Note receivable - long term------
Other long term assets------
Total assets689372344
LIABILITIES
Accounts payable202419
Accrued expenses935430
Notes payable/short-term debt000
Current portion long-term debt/capital leases4.265.105.27
Other current liabilities, total137.447.53
Total current liabilities1309062
Total long term debt131216
Total debt171721
Deferred income tax------
Minority interest------
Other liabilities, total0.360.340.36
Total liabilities14410378
SHAREHOLDERS EQUITY
Common stock414141
Additional paid-in capital1,5641,5641,564
Retained earnings (accumulated deficit)(1069)(1345)(1344)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total9.198.415.62
Total equity545269266
Total liabilities & shareholders' equity689372344
Total common shares outstanding666665
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.